| ILF3-AS1 | gastric cancer | qRT-PCR | H | ✘ | ✘ | ✔ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 32117452 | 2020 |
| ILF3-AS1 | prostate cancer | RNA-seq | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30906477 | 2019 |
| ILF3-AS1 | osteosarcoma | qPCR, Luciferase reporter assay, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 30819403 | 2019 |
| ILF3-AS1 | Malignant melanoma | qPCR, Western blot, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 30588088 | 2018 |
| ILF3-AS1 | melanoma | qPCR, RIP etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 28935763 | 2017 |
| ILF3-AS1 | Cervical cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 34080029 | 2021 |
| ILF3-AS1 | Hepatocellular carcinoma | qRT-PCR;luciferase reporter assays;Western blot; RIP assays | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 34053876 | 2021 |
| ILF3-AS1 | Breast cancer | qRT-PCR | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 33525948 | 2021 |
| ILF3-AS1 | Nasopharyngeal cancer | qRT-PCR; | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 32962500 | 2020 |